Docs Who Lift
Docs Who Lift
Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.
Author
Docs Who Lift
Category
Podcast website
Latest episode
Jul 7, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Menopause Medicine Meets Obesity Care: Doctors React 01.09.2025 39:26
Takeaways Menopausal women often prioritize weight gain concerns over other symptoms. The study observed an association between hormone therapy and weight loss with GLP-1 medications. Retrospective studies have limitations but can provide valuable insights. Future research should focus on randomized controlled trials to confirm findings. The relationship between estrogen and GLP-1 signaling need...
Women’s Fitness Needs Debate: Dr. Stacy Sims vs. Dr. Lauren Colenso-Semple 29.08.2025 1:07:13
We covered: Fasted training Protein timing and many more fitness topics! Hear Dr. Lauren Colenso-Semple and Dr. Stacy Sims discuss outcomes versus mechanisms and much more Tap Here for Dr Stacy Sims References Tap Here for Dr. Colenso-Semples References Dr. LCS Instagram Dr. SS Instagram Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of...
Do You Really Lose Muscle on Semaglutide or Tirzepatide? 22.08.2025 33:50
Takeaways The podcast features Dr. Grant Tinsley, a body composition expert. The discussion revolves around a case series on body composition effects. GLP-1 receptor agonists are a focus of the research. The importance of resistance training in weight loss is emphasized. Patient case studies provide insights into individual experiences. The first patient lost a significant amount of fat mass while...
Predatory Lab Testing: What They’re Not Telling You 16.08.2025 49:50
Takeaways Direct-to-consumer lab testing is on the rise, with significant marketing efforts behind it. Many patients feel brushed off by traditional healthcare providers, leading them to seek alternative testing options. Communication between patients and healthcare providers is often inadequate, contributing to misunderstandings about health. Over-testing can lead to unnecessary anxiety and misin...
CVS Pulled the Plug on Zepbound?! 08.08.2025 20:12
In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the recent changes in obesity medication coverage, particularly focusing on the CVS Caremark decision to drop ZEPBound from their formulary in favor of Wegovi. They explore the implications of this decision for patients and providers, the role of pharmacy benefit managers (PBMs) in healthcare, and the ongoing...
More Than Weight Loss? GLP-1s and Cardiovascular Risk 03.08.2025 11:16
In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the Surpass CVOT trial, which evaluates the cardiovascular outcomes of Monjaro compared to Dulaglutide (Trulicity). They delve into the significance of the trial, the implications of the results, and the potential benefits of Monjaro for patients with type 2 diabetes and cardiovascular risks. The conversation...
Semaglutide vs. Tirzepatide: Are We Closing the Gap? 24.07.2025 41:34
How the STEP-UP trial came to life, and what made the 7.2mg dose possible What the data actually says about weight loss and side effects at higher doses Why trial design, pharmacokinetics, and estimands matter more than you think What’s coming next in obesity meds: duals, triples, and even antagonists The real talk on intermittent fasting, access issues, and preaching vs. science Sign up for Dr....
Clinical vs Anthropometric Obesity 02.07.2025 31:36
Takeaways The study examines the overlap between clinical and anthropometric obesity. Anthropometric measures include waist circumference, waist-to-hip ratio, and BMI. Challenges exist in applying the Lancet Commission's definitions in clinical practice. Metabolically healthy obesity is a debated topic in obesity research. The study highlights the importance of data from the All of Us Research Pro...
GLP-1 meds and macular degeneration 23.06.2025 33:33
Learn what age-related macular degeneration (AMD) is What causes AMD The types of AMD The update on NAION - listen to last year's podcast all about it Why we aren't too concerned Click here to join Dr. Spencer's online clinic Vineyard Click to read the JAMA AMD article Click to read the Ophthalmology journal AMD article Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information...
Menopause, MHT, and GLP-1 medicines 12.06.2025 27:48
Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopause Weight management in women is influenced by hormonal changes throughout life stages. Retrospective analyses can provide insights but have limitations. The wellness industry often oversimplifies complex medical issues. Hormonal replacement therapy may have subtle benefits for weight management. C...
The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass 06.06.2025 28:28
Dr. Grant Tinsley joins the discussion as the body composition expert. Myostatin is a key regulator of muscle growth. Wendy Whippete the most jacked muscled up dog The concern of GLP-1 receptor agonists and muscle mass loss. Overview of Courage trial looking at semaglutide and trevogrumab and lean mass loss Upcoming Believe trial coming out (bimagrumab and semaglutide) Exercise remains crucial for...
Current State of Nutrition Research and MAHA 29.05.2025 56:22
Takeaways: The MAHA report aims to address public health issues but lacks actionable policies. Historical context is crucial for understanding current dietary guidelines. Funding for nutrition research has been inadequate, impacting the quality of data. Public perception of nutrition often outpaces scientific evidence. The evolution of dietary guidelines reflects political and social influences. T...
Joy Prescriptions 13.05.2025 46:48
Click to read Joy Prescriptions Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions. Learn how to stop chasing perfection and embrace connection. 00:00Introduction to Dr. Tiffany Moon 02:02Journey to Reality TV: The Real Housewives of Dallas 05:58Life After Reality TV: Finding Joy and Purpose 09:59The Joy Prescription: A New Approach to Life 17:01Work-Life Integration: Bala...
Zepbound versus Wegovy 12.05.2025 20:57
Tirzepatide is more effective for weight loss than semaglutide. Cost-effectiveness is crucial in prescribing weight loss medications. Patients with severe obesity should receive more expensive medications for better outcomes. Both medications show significant benefits for obesity-related conditions. Long-term studies indicate sustained weight loss with both drugs. Gender differences affect weight...
Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH). 02.05.2025 22:20
Takeaways MASH is a significant obesity-related complication. Semaglutide shows promise in treating MASH. Weight loss is crucial for improving liver health. Bariatric surgery remains the most effective treatment. The Essence trial indicates a 63% resolution of NASH. New medications are being developed for obesity treatment. Early intervention is key to preventing severe liver damage. Accessibility...
Top 5 Women's Fitness Myths 25.04.2025 36:48
Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women. Follow Dr. Lauren's instagram Join Dr. Spencer's online clinic Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
GLP-1 and metabolism and depression 11.04.2025 25:00
Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case of tirzepatide induced anhedonia. Here is the tirzepatide study If interested in joining Dr. Spencer's clinic Vineyard - Click Here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Do GLP-1 meds cause more fat cells? 19.03.2025 25:52
Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells. Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine. Join Dr. Spencer's online clinic that specializes in GLP-1 medicines Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advert...
Future of medicine - Direct Care 11.03.2025 23:15
Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine. Learn about how bypassing insurance and creating a relationship directly with a doctor can improve your health and save money in the long run. Follow Dr. Qiu on Linked in See Dr. Spencer's direct care model with Vineyard Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information...
Tirzepatide and Muscle Loss with Dr. Grant Tinsley 28.02.2025 27:44
Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is lost with tirzepatide, the most powerful medicine available for weight loss. Learn: The difference between fat free mass and lean mass and lean soft tissue and muscle. If GLP-1 medicines cause muscle loss specifically How to minimize muscle loss when taking these medicines Our new study toget...
The Super Bowl Hims and Hers Ad 17.02.2025 25:05
Drs. Karl and Spencer discuss how bad the Hims and Hers ad was. From an outside perspective, the ad may have seemed good. But when you dig deeper, it was actually really bad. Listen to learn. Join Dr. Spencer's new online clinic - Vineyard. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
NAD and NMN with Dr. Charles Brenner 12.02.2025 38:56
Drs. Karl and Spencer chat with NMN and NAD expert Dr. Charles Brenner all about these supposed longevity supplements. Learn about NAD metabolism Whether it's worth supplementing or not with NAD or NMN Follow Dr. Brenner on Twitter Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The 60 Minutes Obesity Doctor - Dr. Fatima Cody Stanford 28.01.2025 45:33
Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes. Does Dr. Sanford believe lifestyle doesn't matter for obesity? Find out by listening! Watch Dr. Stanford's 60 minute clip Join Dr. Spencer's Obesity Clinic Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data...
New Obesity Definition and Higher Wegovy Dose 20.01.2025 29:12
Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on high dosed Wegovy. Learn: How 7.2 mg of Wegovy (semaglutide) compares to 2.4 mg What the proposed definitions of clinical and preclinical obesity are Click here to join Dr. Spencer's new online clinic Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information abou...
The Ozempic Revolution - with Dr. Sowa 10.01.2025 31:15
Drs. Karl and Spencer chat with Dr. Sowa about her book The Ozempic Revolution. Learn: Why she wrote the book. The top 3 things to know when starting a GLP-1 medicine. Also hear the top criticism from Drs. Karl and Spencer. You will laugh. Click here to get the book If you're on a GLP-1 currently and want to switch to Dr. Spencer's new clinic, Click Here Hosted by Simplecast, an AdsWizz company. S...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.